Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 746

1.

IBS in IBD: A label to stick with caution.

Hirten R, Colombel JF.

Clin Gastroenterol Hepatol. 2017 Apr 11. pii: S1542-3565(17)30444-5. doi: 10.1016/j.cgh.2017.04.008. [Epub ahead of print] No abstract available.

PMID:
28410893
2.

Trends in Narcotic and Corticosteroid Prescriptions in Patients with Inflammatory Bowel Disease in the United States Ambulatory Care Setting from 2003 to 2011.

Narula N, Borges L, Steinhart AH, Colombel JF.

Inflamm Bowel Dis. 2017 Mar 31. doi: 10.1097/MIB.0000000000001084. [Epub ahead of print]

PMID:
28368911
3.

Exposure-Efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease.

Rosario M, French JL, Dirks NL, Sankoh S, Parikh A, Yang H, Danese S, Colombel JF, Smyth M, Sandborn WJ, Feagan BG, Reinisch W, Sands BE, Sans M, Fox I.

J Crohns Colitis. 2017 Feb 17. doi: 10.1093/ecco-jcc/jjx021. [Epub ahead of print]

PMID:
28333288
4.

Eldelumab [anti-interferon-γ-inducible protein-10 antibody] Induction Therapy for Active Crohn's Disease: a Randomised, Double-blind, Placebo-controlled Phase IIa Study.

Sandborn WJ, Rutgeerts P, Colombel JF, Ghosh S, Petryka R, Sands BE, Mitra P, Luo A.

J Crohns Colitis. 2017 Feb 22. doi: 10.1093/ecco-jcc/jjx005. [Epub ahead of print]

PMID:
28333187
5.

Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials.

Panés J, Sandborn WJ, Schreiber S, Sands BE, Vermeire S, D'Haens G, Panaccione R, Higgins PD, Colombel JF, Feagan BG, Chan G, Moscariello M, Wang W, Niezychowski W, Marren A, Healey P, Maller E.

Gut. 2017 Feb 16. pii: gutjnl-2016-312735. doi: 10.1136/gutjnl-2016-312735. [Epub ahead of print]

6.

Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study.

Bouhnik Y, Carbonnel F, Laharie D, Stefanescu C, Hébuterne X, Abitbol V, Nachury M, Brixi H, Bourreille A, Picon L, Bourrier A, Allez M, Peyrin-Biroulet L, Moreau J, Savoye G, Fumery M, Nancey S, Roblin X, Altwegg R, Bouguen G, Bommelaer G, Danese S, Louis E, Zappa M, Mary JY; GETAID CREOLE Study Group..

Gut. 2017 Jan 24. pii: gutjnl-2016-312581. doi: 10.1136/gutjnl-2016-312581. [Epub ahead of print]

7.

Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?

Moussata D, Allez M, Cazals-Hatem D, Treton X, Laharie D, Reimund JM, Bertheau P, Bourreille A, Lavergne-Slove A, Brixi H, Branche J, Gornet JM, Stefanescu C, Moreau J, Marteau P, Pelletier AL, Carbonnel F, Seksik P, Simon M, Fléjou JF, Colombel JF, Charlois AL, Roblin X, Nancey S, Bouhnik Y, Berger F, Flourié B; and the GETAID..

Gut. 2017 Jan 23. pii: gutjnl-2016-311892. doi: 10.1136/gutjnl-2016-311892. [Epub ahead of print]

PMID:
28115492
8.

Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus.

Vuitton L, Peyrin-Biroulet L, Colombel JF, Pariente B, Pineton de Chambrun G, Walsh AJ, Panes J, Travis SP, Mary JY, Marteau P.

Aliment Pharmacol Ther. 2017 Mar;45(6):801-813. doi: 10.1111/apt.13948. Epub 2017 Jan 23.

PMID:
28112419
9.

Colonic Pseudopolyps Resulting in Iron Deficiency Anemia.

Hirten R, Cohen BL, Colombel JF.

Clin Gastroenterol Hepatol. 2017 May;15(5):A27. doi: 10.1016/j.cgh.2017.01.007. Epub 2017 Jan 19. No abstract available.

PMID:
28110094
10.

Inflammatory bowel disease among patients with psoriasis treated with ixekizumab: A presentation of adjudicated data from an integrated database of 7 randomized controlled and uncontrolled trials.

Reich K, Leonardi C, Langley RG, Warren RB, Bachelez H, Romiti R, Ohtsuki M, Xu W, Acharya N, Solotkin K, Colombel JF, Hardin DS.

J Am Acad Dermatol. 2017 Mar;76(3):441-448.e2. doi: 10.1016/j.jaad.2016.10.027. Epub 2016 Dec 24.

11.

Five-year Safety Data From ENCORE, a European Observational Safety Registry for Adults With Crohn's Disease Treated With Infliximab [Remicade®] or Conventional Therapy.

D'Haens G, Reinisch W, Colombel JF, Panes J, Ghosh S, Prantera C, Lindgren S, Hommes DW, Huang Z, Boice J, Huyck S, Cornillie F; ENCORE investigators..

J Crohns Colitis. 2016 Dec 26. pii: jjw221. doi: 10.1093/ecco-jcc/jjw221. [Epub ahead of print]

PMID:
28025307
12.

The effects of aminosalicylates or thiopurines on the risk of colorectal cancer in inflammatory bowel disease.

Carrat F, Seksik P, Colombel JF, Peyrin-Biroulet L, Beaugerie L; CESAME Study Group..

Aliment Pharmacol Ther. 2017 Feb;45(4):533-541. doi: 10.1111/apt.13897. Epub 2016 Dec 19.

PMID:
27995656
13.

Inflammatory Bowel Disease 2017: Innovations and Changing Paradigms.

Colombel JF, Mahadevan U.

Gastroenterology. 2017 Feb;152(2):309-312. doi: 10.1053/j.gastro.2016.12.004. Epub 2016 Dec 10. No abstract available.

PMID:
27960091
14.

Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis.

Gordon KB, Colombel JF, Hardin DS.

N Engl J Med. 2016 Nov 24;375(21):2102. doi: 10.1056/NEJMc1610828. No abstract available.

PMID:
27959738
15.

Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.

Feagan BG, Sandborn WJ, Gasink C, Jacobstein D, Lang Y, Friedman JR, Blank MA, Johanns J, Gao LL, Miao Y, Adedokun OJ, Sands BE, Hanauer SB, Vermeire S, Targan S, Ghosh S, de Villiers WJ, Colombel JF, Tulassay Z, Seidler U, Salzberg BA, Desreumaux P, Lee SD, Loftus EV Jr, Dieleman LA, Katz S, Rutgeerts P; UNITI–IM-UNITI Study Group..

N Engl J Med. 2016 Nov 17;375(20):1946-1960.

PMID:
27959607
16.

Response to Cote-Daigneaut et al.

Ungaro R, Chang HL, Colombel JF.

Am J Gastroenterol. 2016 Dec;111(12):1851-1852. doi: 10.1038/ajg.2016.457. No abstract available.

PMID:
27924092
17.

Ulcerative colitis.

Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF.

Lancet. 2016 Nov 30. pii: S0140-6736(16)32126-2. doi: 10.1016/S0140-6736(16)32126-2. [Epub ahead of print] Review.

PMID:
27914657
18.

Crohn's disease.

Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L.

Lancet. 2016 Nov 30. pii: S0140-6736(16)31711-1. doi: 10.1016/S0140-6736(16)31711-1. [Epub ahead of print] Review.

PMID:
27914655
19.

Post-operative recurrence of Crohn's disease after definitive stoma: an underestimated risk.

Koriche D, Gower-Rousseau C, Chater C, Duhamel A, Salleron J, Tavernier N, Colombel JF, Pariente B, Cortot A, Zerbib P.

Int J Colorectal Dis. 2017 Apr;32(4):453-458. doi: 10.1007/s00384-016-2707-2. Epub 2016 Nov 24.

PMID:
27885481
20.

Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventional therapy.

Colombel JF, Jharap B, Sandborn WJ, Feagan B, Peyrin-Biroulet L, Eichner SF, Robinson AM, Mostafa NM, Zhou Q, Thakkar RB.

Aliment Pharmacol Ther. 2017 Jan;45(1):50-62. doi: 10.1111/apt.13838. Epub 2016 Nov 7.

Supplemental Content

Loading ...
Support Center